Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000225643.1 Motesanib Colon adenocarcinoma 0.012645531 Resistant
ENSG00000225643.1 Motesanib Breast invasive carcinoma 0.035669932 Sensitive
ENSG00000225643.1 Motesanib Stomach adenocarcinoma 0.047434073 Sensitive